Amgen Inc. AMGN NASDAQ

Amgen Inc. (AMGN) reported strong year-over-year revenue growth of +10% through 2025-12 (TTM revenue vs prior-year TTM). Net income showed exceptional earnings expansion of +88.5% YoY, reaching $1.3B in the latest quarter. The net profit margin is 13.5%, which is moderate. The company has maintained profitability in all 4 quarters. The gross margin is 70.1% (high), up 8.8pp vs the prior year. With a $189B market cap, MOAT composite score of 90/100 (strong competitive position).

Criteria proven by this page:

• GROWTH (80/100, Pass) — proving strong growth momentum
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 40-year annual history, the company was profitable in 38 of 40 years — an excellent long-term track record
• INCOME (85/100, Partial) — the company is profitable but margin is below 15%
• MOAT (90/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 64/100 with 4/7 criteria passed.